MedTrace Logo

Memory Consolidation in Pharmacologically Enhanced Naps

NCT00777829 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-07-28

Study results available
· View outcomes & findings →

Summary

This study will examine whether various drugs affecting sleep cycles can improve different kinds of memory.

Conditions

  • Sleep

Interventions

DRUG

zolpidem

Participants will receive one dose of 10 mg before each nap.

DRUG

Placebo

Participants will receive a dose of placebo before each nap.

Sponsors & Collaborators

Principal Investigators

  • Sara C. Mednick, PhD · UCSD

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-09-01
Primary Completion
2011-06-01
Completion
2011-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00777829 on ClinicalTrials.gov